MedMira’s patented Rapid Vertical Flow® (RVF) technology makes it possible to capture different biomarkers on a single carrier membrane and thus obtain multiple results simultaneously. Such combined antibody tests increase the efficiency and accuracy of rapid serological tests enormously.
In a globally networked world, the healthcare system will be confronted with new, unprecedented challenges in the future. Efficient and fast mass tests are becoming increasingly important in order to detect possible diseases at an early stage and to prevent epidemics or even pandemics.
Not only hygiene standards, distance rules or protective measures such as masks and gloves can reduce the risk of infection. Knowledge of possible diseases and immunities can also significantly improve occupational safety.